Kathryn E Falberg's Net Worth

$88.5 Million

Estimate Recalculated Sep 18, 2024 05:51PM EST

Who is Kathryn E Falberg?

Kathryn E Falberg has an estimated net worth of $88.5 Million. This is based on reported shares across multiple companies, which include Trade Desk, Inc., Nuvation Bio Inc., BIOMARIN PHARMACEUTICAL INC, JAZZ PHARMACEUTICALS INC, Tricida, Inc., HALOZYME THERAPEUTICS INC, Arcus Biosciences, Inc., UroGen Pharma Ltd., QLT INC/BC, Axovant Sciences Ltd., aTYR PHARMA INC, ARCA biopharma, Inc., Aimmune Therapeutics, Inc., MEDIVATION, INC., and HUMAN GENOME SCIENCES INC.

SEC CIK

Kathryn E Falberg's CIK is 0001206977

Past Insider Trading and Trends

2016 was Kathryn E Falberg's most active year for acquiring shares with 14 total transactions. Kathryn E Falberg's most active month to acquire stocks was the month of April. 2020 was Kathryn E Falberg's most active year for disposing of shares, totalling 22 transactions. Kathryn E Falberg's most active month to dispose stocks was the month of October. 2012 saw Kathryn E Falberg paying a total of $2,356,258.83 for 435,782 shares, this is the most they've acquired in one year. In 2024 Kathryn E Falberg cashed out on 459,090 shares for a total of $23,163,700.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Trade Desk, Inc. (TTD) Snapshot price: $97.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-60.75%
-150.00K
$98.17
-$14,725,500.00
96.91K
Aug 13
Form 4
+1.77%
4.3K
$87.16
$99,885.36
246.91K
May 28
Form 4
—
0
$41.85
-$8,252,437.61
242.61K
Mar 8
Form 4
+2.46%
5.84K
$62.52
$99,906.96
242.61K
May 25
Form 4/A
—
0
—
—
0
Form 4
-0.01%
-21.00
$59.83
-$1,256.43
236.75K
Feb 6
Form 4
+2.32%
5.36K
$59.83
$70,898.55
236.77K
May 26
Form 4
-75.00%
-150.00K
$108.59
-$16,288,480.63
50K
Nov 19
Form 4
+18.93%
500
$639.65
$70,361.50
3.14K
May 27
Form 4
—
0
$813.17
-$16,263,340.42
2.64K
Nov 19
Form 4
+78.93%
1.17K
$249.66
$65,910.24
2.64K
May 26
Form 4
-58.11%
-29.79K
$207.02
-$6,165,584.66
21.48K
Nov 11
Form 4
+14.35%
1.48K
$207.03
$80,741.70
11.76K
Apr 30
Form 4
-66.67%
-40.00K
$205.47
-$8,218,964.00
20K
Mar 11
Form 4
-15.73%
-20.50K
$134.83
-$2,696,692.00
109.79K
Sep 21 - Nov 28
Form 4
+12.74%
5.68K
$49.44
$80,982.72
50.29K
May 3
Form 4
+11.51%
4.6K
$54.52
$70,985.04
44.6K
Jul 20
Form 4
+33.33%
20K
$48.06
$961,154.00
80K
Jun 15
Form 4
+50.00%
20K
$43.38
$867,664.00
60K
Mar 1
Form 4
∞
80K
$25.85
$2,067,800.00
80K
Nov 14 - Nov 15
Form 3
—
0
—
—
0
No matching records found

Nuvation Bio Inc. (NUVB) Snapshot price: $2.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 3
Form 4
—
0
—
—
0
May 15
Form 4
∞
250K
$1.94
$483,835.81
250K
Nov 30 - Dec 5
Form 4/A
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Oct 29
Form 4
—
0
—
—
0
Feb 10
Form 3
—
0
—
—
0
No matching records found

BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
∞
2.64K
—
—
2.64K
Jul 15
Form 4
∞
3.3K
—
—
3.3K
Jul 15
Form 3
—
0
—
—
0
No matching records found

Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14

EVP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.14%
-1.54K
$157.60
-$242,388.80
133.39K
Mar 5
Form 4
+8.18%
10.2K
$7.35
$74,999.40
134.93K
Feb 26
Form 4
-1.58%
-2.00K
$157.00
-$314,000.00
124.72K
Scheduled
Feb 12
Form 4
-1.55%
-2.00K
$131.82
-$263,640.00
126.72K
Scheduled
Jan 8
Form 4
-2.28%
-3.00K
$120.50
-$361,500.00
128.72K
Scheduled
Dec 11
Form 4
-2.23%
-3.00K
$100.88
-$302,640.00
131.37K
Scheduled
Nov 13
Form 4
-2.18%
-3.00K
$83.10
-$249,300.00
134.37K
Scheduled
Oct 9
Form 4
-2.14%
-3.00K
$87.52
-$262,560.00
137.37K
Scheduled
Sep 11
Form 4
-2.09%
-3.00K
$81.02
-$243,060.00
140.37K
Scheduled
Aug 14
Form 4
-2.36%
-3.46K
$80.88
-$280,168.32
143.37K
Aug 9
Form 4
-2.00%
-3.00K
$72.40
-$217,200.00
146.84K
Scheduled
Jul 10
Form 4
+11.99%
16K
—
—
149.42K
Mar 5
Form 4
+49.57%
44.22K
$7.35
$324,987.60
133.42K
Mar 5
Form 4
-40.33%
-60.00K
$47.53
-$2,853,570.00
88.78K
Aug 16
Form 4
+57.58%
35K
—
—
95.78K
Aug 9
Form 4
+4.43%
2.58K
$6.43
$16,595.83
60.78K
May 31
Form 4
∞
111.2K
—
—
111.2K
Jan 18
Form 3
—
0
—
—
0
Form 4
-100.00%
-111.20K
—
—
0
Jan 18
Form 4
+1,597.81%
54.77K
$31.63
-$2,151,807.20
58.2K
Jan 11
Form 4
+221.88%
2.36K
$6.43
$15,194.09
3.43K
Nov 30
Form 4
+6.00%
3K
$37.36
$112,080.00
53K
Nov 11
Form 4
+81.74%
479
$6.43
$3,079.97
1.06K
May 31
Form 4
—
0
—
—
0
Mar 10
Form 4
∞
586
$6.43
$3,767.98
586
Nov 30
Form 4
∞
50K
$8.72
$436,224.40
50K
Aug 30 - Aug 31
Form 4
—
0
—
—
0
Mar 8
Form 4
—
0
—
—
0
Dec 7
Form 3
—
0
—
—
0
No matching records found

Tricida, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
+38.36%
16.4K
—
—
59.16K
Jun 10
Form 4
+15.29%
5.67K
—
—
42.76K
Jun 11
Form 4
+5.34%
1.88K
—
—
37.09K
May 31
Form 4
∞
35.21K
$19.00
$600,001.00
35.21K
Jul 2
Form 3
—
0
—
—
0
No matching records found